An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease. A triple drug combination of the anti-filarial drugs ivermectin, diethylcarbamazine (DEC) and albendazole (IDA) has been shown to be safe and effective for achieving sustained clearanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Supali, Taniawati, Djuardi, Yenny, Christian, Michael, Iskandar, Elisa, Alfian, Rahmat, Maylasari, Roospita, Destani, Yossi, Lomiga, Adriani, Minggu, Dominikus, Lew, Daphne, Bogus, Joshua, Weil, Gary J., Fischer, Peter U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031952/
https://www.ncbi.nlm.nih.gov/pubmed/33780481
http://dx.doi.org/10.1371/journal.pntd.0009294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031952/
https://www.ncbi.nlm.nih.gov/pubmed/33780481
http://dx.doi.org/10.1371/journal.pntd.0009294

Ejemplares similares